Type I collagen-induced pro-MMP-2 activation is differentially regulated by H-Ras and N-Ras in human breast epithelial cells

Journal of Biochemistry and Molecular Biology

Volumn 40, Issue 5, 2007, Pages 825-831

  Kim, InYoung ^a,b   Jeong, Seo Jin ^a,b   Kim, Eun Sook ^a   Seung, Hee Kim ^b   Moon, Aree ^a  

^a Duksung Women's University   (South Korea)

^b National Institute of Toxicological Research   (South Korea)

Author keywords

MMP 2 activation; MT1 MMP; Ras; TIMP 2

Indexed keywords

EID: 35348855017     PISSN: 12258687     EISSN: 02191024     Source Type: Journal    
DOI: 10.5483/bmbrep.2007.40.5.825     Document Type: Article

References (40)

1. Azzam, H. S. and Thompson, E. W. (1992) Collagen-induced activation of the M(r) 72,000 type IV collagenase in normal and malignant human fibroblastoid cells. Cancer Res. 15, 4540-4544.
2. Borg, K. T., Burgess, W., Terracio, L. and Borg, T. K. (1997) Expression of Metalloproteases by Cardiac Myocytes and Fibroblasts In Vitro. Cardiovasc. Pathol. 6, 261-269.
3. Boyd, P. J., Doyle, J., Gee, E., Pallan, S. and Haas, T. L. (2005) MAPK signaling regulates endothelial cell assembly into networks and expression of MT1-MMP and MMP-2. Am. J. Physiol. Cell Physiol. 288, 659-668.
4. Butler, G. S., Butler, M. J., Atkinson, S. J., Will, H., Tamura, T., van Westrum, S. S., Crabbe, T., Clements, J., d'Ortho, M. P. and Murphy, G. (1998) The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study. J. Biol. Chem. 273, 871-880.
5. Carbone, A., Gusella, G. L., Radzioch, D. and Varesio, L. (1991) Human Harvey-ras is biochemically different from Kirsten- or N-ras. Oncogene 6, 731-737.
6. Carloni, V., Romanelli, R. G., Pinzani, M., Laffi, G. and Gentilini, P. (1996) Expression and function of integrin receptors for collagen and laminin in cultured human hepatic stellate cells. Gastroenterology 110, 1127-1136.
7. Clair, T., Miller, W. and Cho-Chung, Y. (1987) Prognostic significance of the expression of the ras protein with a molecular weight of 21,000 by human breast cancer. Cancer Res. 49, 5290-5293.
8. Clark, G. J. and Der, C. J. (1995) Aberrant function of the Ras signal transduction pathway in human breast cancer. Breast Cancer Res. Treat. 35, 133-144.
9. Deryugina, E. I., Bourdon, M. A., Reisfeld, R. A. and Strongin, A. (1998) Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2. Cancer Res. 58, 3743-3750.
10. Deryugina, E. I., Ratnikov, B., Monosov, E., Postnova, T. I., DiScipio, R., Smith, J. W. and Strongin, A. Y. (2001) MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells. Exp. Cell Res. 263, 209-223.
11. Ellerbroek, S. M., Fishman, D. A., Kearns, A. S., Bafetti, L. M. and Stack, M. S. (1999) Ovarian carcinoma regulation of matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase through β1 integrin. Cancer Res. 59, 1635-1641.
12. Fidler, I. J. (1990) Critical factors in the biology of human cancer metastasis. Cancer Res. 50, 6130-6138.
13. Gilles, C., Polette, M., Seiki, M., Birembaut, P. and Thompson, E. W. (1997) Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma. Lab. Invest. 76, 651-660.
14. Goldberg, G. I., Marmer, B. L., Grant, G. A., Eisen, A. Z., Wilhelm, S. and He, C. S. (1989) Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. Proc. Natl. Acad. Sci. USA 86, 8207-8211.
15. Guo, C. and Piacentini, L. (2003) Type I collagen-induced MMP-2 activation coincides with up-regulation of membrane type 1-matrix metalloproteinase and TIMP-2 in cardiac fibroblasts. J. Biol. Chem. 278, 46699-46708.
16. Haas, T. L., Davis, S. J. and Madri, J. A. (1998) Three-dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells. J. Biol. Chem. 273, 3604-3610.
17. Hernandez-Barrantes, S., Toth, M., Bernardo, M. M., Yurkova, M., Gervasi, D. C., Raz, Y., Sang, Q. A. and Fridman, R. (2000) Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation. J. Biol. Chem. 275, 12080-12089.
18. Imai, K., Ohuchi, E., Aoki, T., Nomura, H., Fujii, Y., Sato, H., Seiki, M. and Okada, Y. (1996) Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2. Cancer Res. 56, 2707-2710 .
19. Kim, M. S., Lee, E. J., Choi kim, H. R. and Moon, A. (2003) p38 kinase is a key signaling molecule for H-ras-induced cell motility and invasive phenotype in human breast epithelial cell. Cancer Res. 63, 5454-5461.
20. Kinoshita, T., Sato, H., Okada, A., Ohuchi, E., Imai, K., Okada, Y. and Seiki, M. (1998) TIMP-2 promotes activation of progelatinase A by membrane-type 1 matrix metalloproteinase immobilized on agarose beads. J. Biol. Chem. 273, 16098-16103.
21. Lee, A. Y., Akers, K. T., Collier, M., Li, L., Eisen, A. Z. and Seltzer, J. L. (1997) Intracellular activation of gelatinase A (72-kDa type IV collagenase) by normal fibroblasts. Proc. Natl. Acad. Sci. USA 94, 4424-4429.
22. MacDougall, J. R. and Matrisian, L. M. (1995) Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev. 14, 351-362.
23. Moon, A., Kim, M. S., Kim, T. G., Kim, S. H., Kim, H. E., Chen, Y. Q. and Choi Kim, H. R. (2000) H-ras, but not N-ras, induces an invasive phenotype in human breast epithelial cells: a role for MMP-2 in the H-ras-induced invasive phenotype. Int. J. Cancer. 85, 176-181.
24. Munshi, H. G., Wu, Y. I., Mukhopadhyay, S., Ottaviano, A. J., Sassano, A., Koblinski, J. E., Platanias, L. C. and Stack, M. S. (2004) Differential regulation of membrane type 1-matrix metalloproteinase activity by ERK 1/2- and p38 MAPK-modulated tissue inhibitor of metalloproteinases 2 expression controls transforming growth factor-beta1-induced pericellular collagenolysis. J. Biol. Chem. 279, 39042-39050.
25. Rhee, J. W., Lee, K. W., Kim, D., Lee, Y., Jeon, O. H., Kwon, H. J. and Kim, D. S. (2007) NF-kappaB-dependent regulation of matrix metalloproteinase-9 gene expression by lipopolysaccharide in a macrophage cell line RAW 264.7. J. Biochem. Mol. Biol. 40, 88-94.
26. Sato, H., Takino, T. and Miyamori, H. (2005) Roles of membrane-type matrix metalloproteinase-1 in tumor invasion and metastasis. Cancer Sci. 96, 212-217.
27. Seiki, M. (2002) The cell surface: the stage for matrix metalloproteinase regulation of migration. Curr. Opin. Cell Biol. 14, 624-632.
28. Seltzer, J. L., Lee, A. Y., Akers, K. T., Sudbeck, B., Southon, E. A., Wayner, E. A. and Eisen, A. Z. (1994) Activation of 72-kDa type IV collagenase/gelatinase by normal fibroblasts in collagen lattices is mediated by integrin receptors but is not related to lattice contraction. Exp. Cell Res. 213, 365-374.
29. Shin, I., Kim, S., Song, H., Kim, H. R. and Moon, A. (2005) HRas-specific activation of Rac-MKK3/6-p38 pathway: its critical role in invasion and migration of breast epithelial cells. J. Biol. Chem. 280, 14675-14683.
30. Song, H., Ki, S. H., Kim, S. G. and Moon, A. (2006) Activating transcription factor 2 mediates matrix metalloproteinase-2 transcriptional activation induced by p38 in breast epithelial cells. Cancer Res. 66, 10487-10496.
31. Stetler-Stevenson, W. G., Liotta, L. A. and Kleiner, D. E. (1993) Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J. 15, 1434-1441.
32. Strongin, A. Y., Collier, I., Bannikov, G., Marmer, B. L., Grant, G. A. and Goldberg, G. I. (1995) Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J. Biol. Chem. 270, 5331-5338.
33. Theret, N., Lehti, K., Musso, O. and Clement, B. (1999) MMP2 activation by collagen I and concanavalin A in cultured human hepatic stellate cells. Hepatology 30, 462-468.
34. Tomasek, J. J., Halliday, N. L., Updike, D. L., Ahern-Moore, J. S., Vu Tk, Liu, R. W. and Howard, E. W. (1997) Gelatinase A activation is regulated by the organization of the polymerized actin cytoskeleton. J. Biol. Chem. 272, 7482-7487.
35. Tryggvason, K. (1993) Type IV collagenase in invasive tumors. Breast Cancer Res. 24, 209-218.
36. Ura, H., Bonfil, R. D., Reich, R., Reddel, R., Pfeifer, A., Harris, C. C. and Klein-Szanto, A. J. P. (1989) Expression of type IV collagenase and procollagen genes and its correlation with the tumorigenic, invasive, and metastatic abilities of oncogene-transformed human bronchial epithelial cells. Cancer Res. 49, 4615-4621.
37. Wang, Z., Juttermann, R. and Soloway, P. D. (2000) TIMP-2 is required for efficient activation of proMMP-2 in vivo. J. Biol. Chem. 275, 26411-26415.
38. Watson, D. M., Elton, R. A., Jack, W. J., Dixon, J. M., Chetty, U. and Miller, W. R. (1991) The H-ras oncogene product p21 and prognosis in human breast cancer. Breast Cancer Res. Treat. 17, 161-169.
39. Yang, C., Zeisberg, M. J., Lively, C., Nyberg, P., Afdhal, N. and Kalluri, R. (2003) Integrin alpha1beta1 and alpha2beta1 are the key regulators of hepatocarcinoma cell invasion across the fibrotic matrix microenvironment. Cancer Res. 63, 8312-8317.
40. Yoon, S. O., Park, S. J., Yun, C. H. and Chung, A. S. (2003) Roles of matrix metalloproteinases in tumor metastasis and angiogenesis. J. Biochem. Mol. Biol. 36, 128-137.